The Case for Early Treatment in Severe Aortic Stenosis (SAS) Patients: What the Latest Evidence Tells Us-TAVR in Younger Patients: What About Durability? Dr. Megan Coylewright

TAVR in Younger Patients: What About Durability? Dr. Megan Coylewright

Video Transcription

Video Summary

The transcript discusses the considerations for early intervention in aortic stenosis using transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR). It highlights that age alone isn't a determinant for TAVR candidacy; longevity and comorbid conditions are crucial factors. The transcript underscores the need for appropriate patient selection and shared decision-making, considering risks such as valve deterioration and stroke. It also touches on gender disparities in clinical trials and how valve size affects women's outcomes. Current data suggests TAVR performs well compared to SAVR in terms of hemodynamics and long-term durability.

Keywords

aortic stenosis

transcatheter aortic valve replacement

patient selection

gender disparities

hemodynamics